B-cell tumor development in Tet2-deficient mice
Enguerran Mouly(Université Paris-Sud), Olivier Bernard(Bicêtre Hospital)
Cited by 49
Related Papers
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
|Journal of Clinical Oncology|2013|543
AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic <i>IDH2</i> Mutations
|Cancer Discovery|2017|457
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
|Blood|2009|270
Clonal architecture of chronic myelomonocytic leukemias
|Blood|2013|268
Single-cell transcriptomic profiling of the mouse cochlea: An atlas for targeted therapies
|Proceedings of the National Academy of Sciences|2023|88